In conclusion, the findings in the present report demonstrate that inhibition of AChE reduces the incidence of STZ-induced T1D and provides, for the first time, mechanistic evidence that this is achieved through the inhibition of pathogenic Th17 cells. Here, ACHE is linked to type 1 diabetes mellitus.